The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions in eye bulging and double vision, with a favorable safety profile. Enspryng offers patients greater flexibility by allowing self-administration every four weeks during maintenance. This marks an important advance in TED treatment, a rare autoimmune condition that can cause serious vision and facial issues if untreated.
The FDA approval of Roche’s Enspryng as a novel treatment for thyroid eye disease provides context for the health sector's performance on Pluang. For readers following the health sector, here is Pluang's market snapshot as of Oct 16, 2026 10:01 WIB: out of 150 priced US health stocks, 129 rose and 20 fell. Notable movers include COGT at USD 29.64 with a 1-day change of +5.29%, ALNY at USD 235.58 with +4.95%, and CGC at USD 0.75 with +4.94% but with 100% sell order activity and a typical hold time of 39 days.
Tesla has rapidly expanded its Cybercab robotaxi fleet in Austin, increasing the number of vehicles more than eight times within a month to over 300. This significant growth suggests Elon Musk's vision for autonomous robotaxis is gaining traction. Th...
Lavazza, operated by Yum China, has opened its fifth store in Hong Kong less than a year after its first, with plans to expand to around 10 stores soon. The brand is introducing its signature Buffalo Milk Latte, a popular drink in Mainland China made...
Emergent Metals Corp. has filed amended and restated financial statements for Q2 2026 to correct accounting and disclosure issues, affecting share capital and comprehensive loss figures but not net loss or assets. The company also provided an update ...
The PUMP token from Pump.fun fell about 32% from its October 7 high, closing at $0.004534 on October 15. A token burn on October 13 removed 192.3 million PUMP tokens, a small fraction of the total supply, bringing cumulative burns to 171.96 billion t...
Prospera Energy completed workovers on five heavy oil wells in Luseland, Saskatchewan, increasing combined oil production from 15 to 54.5 barrels per day, a 3.6-fold rise, while spending 23% less than budgeted. The company’s reactivation program has ...
